Kidney health may change how this drug works

NCT ID NCT05936138

Completed Knowledge-focused Sponsor: Eli Lilly and Company Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how the drug LY3502970 behaves in people with healthy kidneys compared to those with kidney problems. Researchers measured how much drug gets into the blood and how fast the body clears it. The goal is to understand if kidney impairment changes drug levels, which can help guide proper dosing. 24 adults took part in this single-dose study.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for END-STAGE RENAL DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

end stage renal failure impaired renal function disease kidney failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY RENAL INSUFFICIENCY

Contacts and locations

Locations

Advanced Pharma CR, LLC

Miami, Florida, 33147, United States
Alliance For multispecialty Research, LLC

Knoxville, Tennessee, 37920, United States
Clinical Pharmacology of Miami

Miami, Florida, 33014, United States
Orlando Clinical Research Center

Orlando, Florida, 32809, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.